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Publicly available multi-omic databases, in particular if associated with medical
annotations, are rich resources with the potential to lead a rapid transition from
high-throughput molecular biology experiments to better clinical outcomes for patients.
In this work, we propose a model for multi-omic data integration (i.e., genetic variations,
gene expression, genome conformation, and epigenetic patterns), which exploits a
multi-layer network approach to analyse, visualize, and obtain insights from such
biological information, in order to use achieved results at a macroscopic level. Using
this representation, we can describe how driver and passenger mutations accumulate
during the development of diseases providing, for example, a tool able to characterize
the evolution of cancer. Indeed, our test case concerns the MCF-7 breast cancer cell
line, before and after the stimulation with estrogen, since many datasets are available
for this case study. In particular, the integration of data about cancer mutations, gene
functional annotations, genome conformation, epigenetic patterns, gene expression, and
metabolic pathways in our multi-layer representation will allow a better interpretation of
the mechanisms behind a complex disease such as cancer. Thanks to this multi-layer
approach, we focus on the interplay of chromatin conformation and cancer mutations
in different pathways, such as metabolic processes, that are very important for tumor
development. Working on this model, a variance analysis can be implemented to identify
normal variations within each omics and to characterize, by contrast, variations that can
be accounted to pathological samples compared to normal ones. This integrative model
can be used to identify novel biomarkers and to provide innovative omic-based guidelines
for treatingmany diseases, improving the efficacy of decision trees currently used in clinic.
Keywords: gene functional annotations, chromosome conformation capture, metabolic pathways, epigenetic
patterns, gene expression, cancer mutations, multi-layer networks, damage spreading
INTRODUCTION
The application of high-throughput genomic, proteomic, and transcriptomic experiments has
gradually become an inevitable component for biomedical science. The reason is that omic
data helps the interpretation of the mechanisms that cause the onset of complex diseases. In
particular, these data help in cracking the immense complexity of the cancer genome, improving
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our comprehension of the striking heterogeneity also in
histologically similar tumors (Vucic et al., 2012).
Our approach moves from the consideration that during the
disease progression some omic processes come before others:
typically, mutations are the early factors that influence the
onset of the pathology. For example, we are now able to create
phylogenetic trees of cancers, describing the accumulation of
mutations during time, which transform cells impairing growth
constraints and allowing their invasiveness.
But cells can become pathological also in consequence of
alterations in the surrounding microenvironment, rather than
for mutations in their own DNA, and epigenetics changes reflect
these cellular interactions (Maffini et al., 2004). Recent evidences
in cancer development point to a crosstalk between these two
mechanisms, suggesting that gene mutations have the potential
of disrupting several epigenetic patterns and that epigenetic
modifications can drive genomic instability and mutagenesis.
For example, whole exome sequencing of thousands of human
cancer cells revealed unexpected mutations in genes involved in
epigenetic mechanisms, and those mutations have the potential
to disrupt DNA methylation patterns, histone modifications and
nucleosome positioning (Coppedè et al., 2014).
Beside having direct effects on gene expression, therefore
influencing metabolic pathways, all these pathogenic
mechanisms play a role in reshaping the 3D chromatin
conformation, modifying long-range interactions in the
genome. Indeed, there are evidences that DNA topological
changes occurring during the disease development support
the conversion of cells to a pathological state (Jäger et al.,
2015; Du et al., 2016). Considering cancer, although chromatin
conformation changes are poorly understood during the tumor
development, it is possible to demonstrate that oncogenic
transcription-factors overexpression is associated with
global, reproducible, and functionally coherent changes in
the chromatin organization (Rickman et al., 2012; Taberlay et al.,
2016). A better comprehension of chromatin conformation
modifications can be achieved by integrating data concerning
genetic variations, genome conformation, gene expression,
epigenetic patterns, gene functional regulation, and metabolic
pathways (see Figure 1).
Evidences of the 3D genome conformation role in regulating
and maintaining cellular functions are continuously emerging
(Lieberman-Aiden et al., 2009; Dong et al., 2010; Schoenfelder
et al., 2010; Gerstein et al., 2012; Kalhor et al., 2012; Lan
et al., 2012; Shen et al., 2012; Homouz and Kudlicki, 2013;
Jin et al., 2013; Papantonis and Cook, 2013; Babaei et al.,
2015). For example, pathological genome organizations can be
associated with many diseases, such as muscular dystrophy
(Petrov et al., 2008) and Rett syndrome (Horike et al., 2005).
The genome folding plays a critical role also in chromosomal
rearrangements that occur during the creation of the antibody
repertoire as part of the immunological development (Merelli
et al., 2010; Zhang et al., 2012). Moreover, insertion sites selected
by retroviruses (and retroviral vectors in gene therapy) to inject
their exogenous genomic material in the host genome are largely
influenced by the 3D organization of chromosomes (Biasco et al.,
2011).
For example, Genome-Wide Association Studies (GWAS)
have identified more than 70 common single nucleotide
polymorphisms (SNPs) that are associated with the breast cancer
risk (Michailidou et al., 2013). However, the vast majority
of these SNPs lie in noncoding regions of the genome and
their interpretation is difficult (Merelli et al., 2013a; Kel et al.,
2016). To test whether SNPs regulate their target genes through
long-range chromatin interactions, capture-based sequencing
technology have been used to investigate possible cis-interactions
at different cancer risk loci (Jäger et al., 2015; Du et al., 2016),
finding very interesting results in this sense. More generally, the
association between chromosome conformation and epigenetic
patterns is under investigation, by comparing normal and cancer
tissues. The organization of the chromatin in the nucleus can
be itself a biomarker (Babu and Fullwood, 2015), since specific
reorganizations of the genome in the nucleus can characterize
the early onset of tumors, as it has been demonstrated for breast
cancer (Meaburn et al., 2009).
In the past, researchers were able to study the position of the
DNA in the nucleus through microscopy, using light reflecting
antibodies able to recognize specific genes. However, since 2002,
a technology called Chromosome Conformation Capture (3C)
permits to stabilize the DNA conformation before sequencing the
genome, allowing the identification of sequences that are close
to each other in the 3D space of the nucleus. 3C techniques are
producing a huge amount of data concerning the conformation
of our genome and important studies have already been
accomplished to investigate how the chromatin is organized into
domains of co-ordinately regulated enhancers and promoters
(Shen et al., 2012). However, while there is a rapid growth in
data production and improvements in experimental protocols
(Barutcu et al., 2016), suitable computational approaches are still
required to turn these data into real clinical knowledge.
Experimentally, 3C consists in stabilizing protein-mediated
DNA interactions through formaldehyde. The cross-linked
genome is enzymatically digested and the resulting pieces of
genomic DNA are ligated. This approach generates new binary
connections, relying on the spatial proximity of chromosomes
in the nucleus, which can be sequenced as paired-end reads.
Coupling 3C with massive parallel sequencing allows the study of
the genome folding in the nucleus at unprecedented resolution.
High Throughput 3C methods (HT-3C), such as Hi-C and
chromatin interaction analysis by paired-end tag sequencing
(ChIA-PET), have made it possible to generate genome-wide
data about interactions between chromatin segments at Kb–Mb
resolutions, thus opening the way for studying the 3D genome
conformation at these scales.
Although HT-3C can provide very interesting results, this
experimental procedure is far from being perfect: not all the
established contacts are real and not all the effective contacts
are identified. Even more complex is to interpret data, which
means to understand why a contact is there, trying to explain
the association between two pieces of chromatin (and their
corresponding genomic features) that are near each other inside
the nucleus. Are these genes co-localized because they are
involved in the same metabolic pathway? Are they controlled
by the same genetic and epigenetic regulation? How mutations
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FIGURE 1 | Chromatin conformation as an integrator of omic signals. Cancer can evolve by accumulating many mutations, which impact on the expression
profile of cells, but also collecting from the microenvironment stimuli that boost cell transition to tumor, causing genomic instability. Beside having direct effects on
gene expression, therefore influencing metabolic pathways, all these signals are integrated by the conformation of the DNA in the nucleus. During the development of
the disease, changes in long-range genome interactions impact on cell’s regulatory patterns. By combining all these effects, the expression profile of cells acquires the
typical hallmarks of cancer, changing its metabolic characteristics and modifying its molecular pathways.
impact on the conformation of the DNA in the nucleus? How do
epigenetic factors modulate the genome conformation? Why are
these genes close to each other in some cells, while they are distant
in others? Is the activity of these genes effectively correlated to
their positions? And, the more important: how do changes in the
genome conformation correlate with cancer?
To answer these questions, there are few computational
and statistical solutions at the moment. The most popular
approach to HT-3C data analysis relies on contact maps, which
are matrices of pairwise contact frequencies in the genome.
This representation, despite being simple from a mathematical
point of view, makes difficult to capture the complexity of the
nuclear organization, since it only provides a description of
binary interactions, preventing the creation of a metric about the
distances of different genomic segments. To improve the analysis
of HT-3C data, graph-based approaches have been proposed,
such as CytoHi-C (Shavit, 2013) and Homer (Heinz et al., 2010),
which both rely on Cytoscape for network analysis.
In a previous work we developed NuChart (Merelli et al.,
2013b, 2015), an R package that elaborates Hi-C information
to provide a systems biology oriented, gene-centric view of the
three-dimensional organization of the DNA in the nucleus. In
this paper, we want to improve the graph representation of Hi-
C data discussed in previous works, proposing a multi-level
approach able to integrate different omics using multi-level
networks. This representation can describe in a single model
the topology of the DNA in the nucleus, epigenetic profiles,
cancer mutations, gene functional relations, gene expression, and
metabolic pathways, creating an integrative environment that is
still lacking in multi-omic data analysis.
We will show how this modeling approach is able to
characterize the correlation between the function of some genes,
their spatial distribution and the progression of complex diseases,
such as cancer. Extending gene network representations to multi-
layer models will improve their descriptive power, in order
to identify the mechanisms behind gene co-localization, co-
expression, and co-regulation. Ideally, by defining appropriate
confidence intervals for each different biological feature, we will
be able to introduce the concept of variance analysis for omic
sciences, allowing multi-omic data to be really translational,
since this information can be used to improve decisions in the
treatment of patients and also to ameliorate the predictive power
of survival curves. In particular, we will test this framework
on data from a breast cancer cell line, to describe the spatial,
functional and regulatory differences in two distinct conditions.
MATERIALS AND METHODS
This paper shows how a multi-layer approach for the integration
of different omic datasets, representing multiple aspects of
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the pathology evolution, can be used to model and analyse
heterogeneous data, improving medical treatments and
achieving better predictions about the disease outcomes. Several
bioinformatic tools and network theory concepts have been
combined in a unique framework to achieve an integrative multi-
layer representation of multi-omic data, which are presented
below.
Biological Layers
Although different combinations of networks and scalar data are
possible, the framework we propose is three-layered. The first
layer is composed by data about mutations, mapped on networks
representing gene-to-gene functional similarities, relying on the
Biological Process (BP) domain of the Gene Ontology (GO)
(Peng et al., 2014). In this way, we want to verify if disease
related genomic variations are correlated with specific biological
functions, with a particular interest in metabolism, in order to
characterize critical genes.
The second layer models the genome conformation, since it
represents Hi-C data processed with NuChart (Merelli et al.,
2013b, 2015), on which epigenetic profiles are mapped as features
of the vertices. The choice of mapping epigenetic patterns on
nuclear maps is oriented at studying specific chromatin profiles
that influence the final confirmation of the DNA in the nucleus,
highlighting regulatory patterns.
The third layer is created mapping gene expression profiles
on protein-protein interaction data, as reported in STRING
(Jensen et al., 2009). Therefore, this layer is mainly devoted
at identifying up and down regulated pathways in different
experimental conditions. To achieve the multi-layer model we
useMuxViz (De Domenico et al., 2015), which allows to integrate
these three layers and to apply inter-layer clustering algorithms
(see Figure 2) as well as other diagnostics and modeling tools.
Mutations and Functional Information
The GO initiative provides rich information and a convenient
way to study gene functional similarity, which has been
successfully used in various applications. However, the existing
GO-based gene function similarity measurements are quite
difficult to use and only few tools are able to compute metrics
taking into account the whole ontology structure. To define a
gene functional topology according to GO, a novel integrative
measure (and the related analysis tool) called InteGO2 has been
used, which automatically selects the appropriate seed measures
and then integrates them using a meta-heuristic search method
(Peng et al., 2014). By using this approach, we obtain the first
layer of our representation that describes the functional similarity
of genes, on which information about mutations of disease
associated genes can be mapped.
Many different databases are available to download data about
SNPs involved in specific diseases. For example, one of the most
used databases for genomic variations involved in tumors is
COSMIC, the Catalog Of Somatic Mutations In Cancer (Forbes
et al., 2015), because it is the largest and most comprehensive
resource for exploring the impact of driver and passenger
mutations in human cancers. The latest release describes two
FIGURE 2 | Multi-layer approach to multi-omic data integration. Our
approach consists of a three-layered model to compare cells in different
conditions: the first layer represents the functional similarity of genes
(according to the BP domain of GO) on which mutation data from the COSMIC
database are mapped; the second layer represents the conformation of the
chromatin in the nucleus (according to Hi-C data analyzed with NuChart) on
which epigenetic information of cells are mapped, relying on MeDIP-seq
experiments; the third layer represents a protein-protein interaction network
(according to the STRING database) on which gene expression data are
mapped.
millions of manually curated point mutations in over one million
tumor samples and across most of the human genes.
Hi-C and Epigenetics Data
The second layer of our model describes the genome
conformation and mostly relies on Hi-C data. As introduced,
this method combines Next-Generation Sequencing (NGS) and
3C, a technique in which DNA (together with the proteins that
coordinate the chromatin conformation) is cross-linked with
formaldehyde, enzymatically fragmented, and re-ligated relying
on its physical proximity in the nucleus. From the bioinformatics
point of view, chromatin conformation data have been analyzed
using NuChart (Merelli et al., 2013b, 2015), a complete suite of
tools for the analysis of Hi-C experiments using a gene-centric
point of view, to provide a map on which other omic information
can be mapped.
In order to complete the Hi-C layer, it can be desired
to map epigenetic data on the neighborhood graph of a
gene, such as methylation and histone modification. Typically,
the experiments used to study these epigenetic patterns rely
on chromatin immunoprecipitation sequencing (ChIP-seq), a
method used to analyse protein interactions with DNA. A
possible choice is to use data achieved through Methylated
DNA immunoprecipitation sequencing (MeDIP-seq), a large-
scale purification technique used to enrich for methylated DNA
sequences, which relies on isolating methylated DNA fragments
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via an antibody raised against 5-methylcytosine followed by
massive parallel sequencing.
Interaction and Expression Data
Protein-protein interaction networks are an important ingredient
for the system-level understanding of cellular processes, and
omic data analysis heavily depends on high quality knowledge-
base of pathway maps. A very useful database in this context
is STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) (Jensen et al., 2009). The STRING database
contains information from numerous sources, including
experimental data, computational prediction methods, and
public text collections.
We use the information available in STRING to define the
topology of the third layer of our model, which represents the
phenotype, in terms of gene expression and metabolic pathways,
achieved by pathological cells according to the modifications
of the genome conformation. To this end, the obvious choice
is to map on this layer the expression of genes, in order to
highlight possible correlations between gene co-expression, co-
localization, and co-regulations in cancer cells.
Bioinformatics Pipeline
From the bioinformatic point of view, the multi-layer model
is the result of a pipeline that encompasses a number of steps
in which the tools highlighted above have been employed. The
whole process starts by identifying some genes of interest, called
seed genes.
We start by computing the neighborhood graph for the
seed genes using NuChart, working on the raw sequencing
data, usually downloaded from the NCBI Short Read Archive
(SRA) database, of the appropriate Hi-C experiment (since,
in our example, we need raw sequencing data to create
our neighborhood graphs). Once the Hi-C graph has been
constructed (considering a user defined distance from the seed
gene), we skim the edges list, taking only edges with weight (i.e.,
probability of existence) greater than a specific threshold (default
p < 0.05). From this list of edges, we retrieve all unique genes
that play a part in the current network, and use this list as input
for the InteGO2 web application. With InteGO2 we can compute
the gene-to-gene functional similarity, which is returned as a
network that links genes that are functionally similar. At the
same way, we build the protein-protein interaction network for
the seed genes using the STRING search tool (considering a user
defined distance from the seed gene).
The next step is to map genomic data on the achieved layers:
as already explained, we map epigenetic data on the Hi-C layer,
expression data on the STRING layer, and gene mutations on the
InteGO2 layer, although other combinations are possible.
Concerning epigenetics, experimental results can be typically
downloaded from the NCBI Gene Expression Omnibus (GEO)
database, where pre-processed ChIP-Seq data are publicly
available (in our example, MeDIP-seq data were accessible for the
same cells of the selected Hi-C experiments). The pre-processed
output can be usually downloaded as text files, which contain
enriched peaks (default p < 0.05), usually called using MACS
(Zhang et al., 2008). While rendering graphs, we use the average
value of the considered epigenetic mark, taking into account all
the genes playing a role in the Hi-C layer, as a threshold to
differentiate the graphical look of the nodes and coloring the
vertices accordingly. Moreover, the logarithm of the normalized
epigenetic values is used to determine the graphical size of the
node.
A rather similar approach has been used for mapping
expression data and mutations on the STRING and InteGO2
layers, respectively. Pre-processed expression data can be freely
downloaded both from the EMBL-EBI ArrayExpress database (in
our example, gene expression data were accessible for cells in the
same conditions and at the same time points of the selected Hi-
C experiments) as text files, which contains differential expressed
genes (default p< 0.05). When rendering the graph, we compute
the average expression value of all the genes in the STRING layer,
and we then use this value as a threshold for choosing the color
of the vertices, as explained in the previous paragraph, while the
logarithm of the expression value determines the graphical size of
the node.
At the same way, mutations are mapped on the InteGO2 layer:
the mutation dataset is downloaded from a reference database
(in our example, from the COSMIC catalog), according to the
pathology in analysis, which typically describes, for each gene, the
number of analyzed samples carrying mutations in relation to the
number of tested samples. We use this number for determining
both color and size of the nodes in the GO-based layer, according
to the protocol described above.
Multi-layer Integration
A network representation is useful for describing the structure
of a large variety of complex systems, although most real
frameworks have multiple subsystems and layers of connectivity.
Achieving a deep understanding of such systems necessitates the
generalization of the traditional network theory, and the huge
amount of data generated by NGS is a very interesting ground
to test increasingly complex frameworks for network analysis
(Forbes et al., 2015).
Multi-layer Formalization
When we refer to multi-layer networks we adhere to the
definition provided in (Kivelä et al., 2014), where interconnected
systems are described as networks where many, or even all
the actors of the system have a counterpart in each layer, so
that one can associate a vector of states to each actor. Multi-
layer networks can encode much richer information than the
individual layers separately. This, in turn, provides a suitable
framework for versatile analyses that are widely used to reveal
multi-layer community structures, to identify node clusters, and
to compute correlation statistics between them.
From the mathematical point of view, adjacency matrices
are useful to describe traditional single-layer networks, but such
representations are insufficient for the analysis and description
of interconnected networks. One must therefore develop a more
general mathematical framework to cope with the challenges
posed by multi-layer complex systems. The principal theoretical
foundations for a wide variety of multi-layer networks have been
laid out in Kivelä et al. (2014), in an attempt to present a unifying
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framework to treat both traditional single-layer networks and a
variety of complex networks successfully.
In particular, a graph (i.e., a single-layer network) is a tuple
G = (V, E, w), where V is the set of nodes (or vertices) and E ⊆
V × V is the set of edges that connect pairs of nodes according
to some type of relationship. w is a function w: E → R+ that
assigns a weight to the edge, thus qualifying the relation between
two nodes. We can thus define ei,j as the edge that connects node
i to node j, with wi,j being the weight of the edge that connects
node i and node j. If there is an edge between a pair of nodes
(ei,j, e ∈ E), then those nodes are adjacent to each other. This
edge is incident to each of the two nodes, and two edges that
are incident to the same node are also said to be incident to each
other.
In multi-layer networks, we will use the term adjacency to
describe a connection between a pair of node-layers, and the term
incidence to describe two (or more) edges that connect a node-
layer pair. Follows that two edges that are incident to the same
node-layer pair are also incident to each other. By assembling a
set of layers L using a Cartesian product L1 × . . .× Ld, we can
indicate whether a node is present in a given layer. To do so, we
first construct a set V × L1 × . . .× Ld of all the combinations
of a node and a layer, and then define a subset VM ⊆ V × L1
× . . . × Ld that contains only the node-layer combinations in
which a node is present in the corresponding layer. In multi-layer
networks we also need to specify the starting and ending layers for
each edge: in this perspective, EM is the set of pairs of all possible
combinations of nodes and layers: EM ⊆ VM × VM . Using the
components set up above, a multi-layer network is defined as a
quadrupletM = (VM , EM , V, L).
Multi-layer Representation
MuxViz is a framework designed for the analysis and
visualization of multi-layer networks. It allows an interactive
visualization and exploration of graphs where nodes exhibit
multiple relationships simultaneously, on different layers (De
Domenico et al., 2013). By combining two standard force-
directed algorithms, it determines the positions of nodes in each
layer, and project them to an aggregated network obtained by
summing the corresponding entries of the adjacency matrices of
the individual layers. Specifically, first the Fruchterman–Reingold
algorithm is applied to the aggregated network, and then the
output of this algorithm is used as a seed layout for the Kamada–
Kawai algorithm to achieve a better spatial separation of nodes
in the final layout (De Domenico et al., 2013).
MuxViz provides a generalization of several important
network descriptors—including degree centrality, clustering
coefficients, eigenvector centrality, etc.—by means of tensor
formalisms and higher-order tensor algebra. Tensors provide
a convenient mathematical representation for generalizing
ordinary static networks, and permit to encapsulate complicated
sets of relationships that can also change in time.MuxViz can also
derive the aggregated network from the interconnected structure,
where the edges between two actors are summed up across all
layers. The aggregated layer puts in evidence how topological
descriptors of interconnected networks differ from the ones
corresponding to their aggregated graphs.
Centrality Measures and Correlations
We defined above our single-layer network as tuples G = (V, E,
w), resulting in undirected weighted graphs. The identification of
the most “important” nodes in a system has great importance in
network characterization. Themost intuitive topological measure
of centrality is given by the degree of the nodes: more connected
nodes are more central. The degree of a node di is defined as the
sum of its incident edges:
di = 6j ei,j, e ∈ E, (i, j) ∈ V
We can take into account the degree of each node in each layer
L of our multi-layer model, as well as the degree of the nodes
in the aggregate layer. However, more is not necessarily better:
the weights of the edges differentiate them according to the
relationship that ties the nodes. In our case, nodes relationships
vary according to the information encoded in the graph—
functional similarity, spatial proximity and physical interaction,
respectively. Taking into account the weight of the edges we are
able to analyse the strength of each node si, that is defined as the
sum of weights attached to the edges belonging to a node:
si = 6j ei,jwi,j, e ∈ E, (i, j) ∈ V
This quantity measures the strength of vertices in terms of
the total weight of their connections. In each layer L of our
multi-layer model, connections reflect a particular relationship
quantified with values ranging between 0 and 1, thus reporting
the probability for that relationship to exist. With MuxViz we
can compute the strength of each node in each layer, separately,
plus the strength of the nodes in the aggregate layer, resulting
in a natural measure of the importance of a vertex i in our
model.
Working on the resulting graphs we can apply some centrality
statistics to identify those “important” vertices that are likely
to be highly influential for the dynamics of the described
mode, such as cancer super-spreaders. By using the tensorial
calculation introduced above, MuxViz permits to extend well
known statistics for centrality analysis in multi-layer networks.
Among the others, the HITS centrality (Hyperlink-Induced
Topic Search) is a link analysis algorithm that was introduced
to rank websites in relation to their importance for users. This
approach considers two different descriptors for each node,
namely hub and authority: in the context of theWorldWideWeb,
certain web pages that point to an important page, generally also
point to other important pages, building a structure similar to
a bipartite topology where relevant pages—i.e., authorities—are
pointed by special web pages—i.e., hubs—which are not actually
authoritative in the information that they held, but directly
connect to many other authoritative pages. Follows that nodes
with high authority centrality are linked by nodes with high hub
centrality, while very influential hubs point to nodes which are
very authoritative.
With MuxViz we can also calculate a measure of correlation
(e.g., Pearson or Spearman correlation) between each pair of
descriptors, to obtain a set of pairwise distances and measure
the similarity between layers. The inter-layer assortativitymodule
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computes the Pearson correlation between the degree (and
strength) of nodes and their counterparts in other layers, for all
pairs of layers, so as to measure the linear correlation between
two variables, X and Y, returning a value in the range [+1, −1],
where 1 is total positive correlation, 0 is no correlation, and −1
is total negative correlation. An alternative correlation analysis
is the Spearman correlation, that is again a nonparametric
measure of statistical dependence between two variables, but is
recommended when the assumptions underlying a Pearson test
are not satisfied. This is another measure of similarity between
layers.
THE BREAST CANCER CASE STUDY
To discuss our approach on a specific test case for the
characterization of damage spreading in cancer, we used data
from the MCF-7 breast cancer cell line, for which many
different omic experiments are available. MCF-7 is a breast
cancer cell line isolated in 1970 from a 69-year-old Caucasian
woman, which retained several characteristics of differentiated
mammary epithelium, including the ability to process estradiol
via cytoplasmic estrogen receptors and the capability of forming
domes.
Our primary data source is the work of Mourad et al. (2014),
in which a time series Hi-C experiment has been discussed
as a promising methodology for a better understanding of the
chromatin conformation global dynamics and its link with gene
regulation (GEO:GSE51687). This time series corresponds to
different sampling performed after cell treatment with 17β-
estradiol (E2), the primary female sex hormone, which is
responsible for the development and regulation of the female
reproductive system and secondary sex characteristics. Estrogen
stimulation is an important factor in human breast cancer cell
growth and development, since it leads to genome structure
reconfiguration, thereby disrupting the originally chromatin
structures (Rao et al., 2014).
More precisely, we considered MCF-7 chromatin
conformation experiments performed by Mourad et al. (2014)
at time point 0 and 4 h after 7 × 10−8 M E2 stimulation. These
data have been analyzed with NuChart and only edges having
high statistical significance (p < 0.05) have been retained in the
graphs. For gene expression, we used MCF-7 time-series data
after E2 stimulation from Cicatiello et al. (2010), considering
time points 0 and 4 h after 5 × 10−8 E2 stimulation. These
time points are shared between Hi-C and gene expression
experiments (AE:E-TABM-742) and only differential transcribed
genes (p < 0.05) have been considered. From the epigenetic
point of view, many different aspects play an important role in
cancer evolution. Taking into account publicly available datasets,
we decided to integrate MeDIP-seq data concerning methylation
in MCF-7 from Hsu et al. (2010). These data are from MCF-7
cells that were not stimulated with E2, since methylation patterns
are mostly static in response to E2 within the 24 h (Ross-Innes
et al., 2011; ENCODE Project Consortium, 2012; Putnik et al.,
2012), and only peaks identified with high confidence (p < 0.05)
have been considered in the model (GEO:GSE21068).
In Figures 3, 4 we present two multi-layer graphs, as achieved
with MuxViz, for the breast cancer cell line MCF-7 at time
point 0 and 4 h after E2 stimulation (see Supplementary
Tables 1, 2 for the full gene lists). In particular, these graphs
have been generated using the Estrogen Receptor 1 (ESR1) as
seed gene, which a key regulator for the physiological growth
and differentiation of the mammary gland, but also a key
element for the malignant progression of breast cancer. Once
activated by estrogen, the ESR1 is able to translocate into the
nucleus and bind to DNA to regulate the activity of different
genes, which makes this protein particularly interesting from
the chromosome conformation point of view. Using ESR1 as
input, we identified its neighborhood genes, according to the
available Hi-C experiments. At the same time, we generated
the other layers using InteGO2 and STRING. The fourth level
in Figures 3, 4 represents the aggregate layer, which shows
the whole gene set staged in the other three layers (since, as
discussed above, they can present different genes, due to the
different connections that can be generated using the seed genes
as input of the different tools). The colors and dimensions of
vertices are plotted according to the scalar values assigned to each
node, representing the different multi-omic features, reported in
log scale (see the method section for details). In particular, on
the Hi-C layer we mapped gene methylation, on the STRING
layer we mapped gene expression, and on the gene functional
layer we mapped mutations as retrieved from the COSMIC
database.
As it can be seen from the comparison between Figures 3, 4,
after the E2 stimulation the genes inside the nucleus achieve
a closer conformation, becoming denser around the seed
gene ESR1. This gene also changes its expression, since after
stimulation it expression doubles, which is somehow expected
considering its role in the malignant progression of breast
cancer. However, the most evident variation is the number of
mutations that appear in the network after the stimulation, which
testify for the amount of mutated genes activated by E2. This
evidence highlights how variations can diffuse around few critical
mutations, increasing damage spreading in cancer cells.
More generally, relying on the results achieved genome
wide, this study demonstrates the role of the estrogen on
the global organization of the genome and its link with gene
regulation in cancer. After E2 stimulation the network shows
a more centralized configuration, and methylation patterns
seems anti-correlated to active genes, as expected. Besides
augmenting the number of long-range interactions, E2 induces
a dynamic mechanism of global chromatin reorganization. More
specifically, gene-rich chromosomes as well as areas of open and
highly transcribed chromatins are rearranged to a greater spatial
proximity.
On the other hand, we see a substantial independence between
gene expression and gene co-localization, which can be partially
explained with a general deregulation of physiological pathways.
The impression is that after the E2 stimulation cells are forced
to increase their activity, which results in a generalized growth
of gene expression. From these results, we can conclude that E2
induces a higher spatial compartmentalization of genes, with a
wide activation of genes in open chromatin regions.
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FIGURE 3 | Multi-layer graph for the breast cancer cell line MCF-7 at time point 0 h, before E2 stimulation, considering ESR1 as seed gene. (A)
represents the stacked multilayer (interlayer edges have been removed for readability), while (B) shows each single layer separately. In both panels, from left to right,
the first layer represents the functional similarity of genes relying on the BP domain of GO, as computed by InteGO2. On this network, breast cancer mutation data are
mapped, according to the COSMIC database (colors and dimensions of nodes indicate the number of samples with mutations in the COSMIC dataset for each gene).
The second layer represents the conformation of the chromatin in the nucleus, according to Hi-C experiments analyzed using NuChart. Vertices are colored according
to the methylation of genes, relying on MeDIP-seq experiments. The third layer represents a protein-protein interaction network according to the data reported in the
STRING database. Gene expression data have been mapped on this graph and vertices are represented accordingly. Please note that in each layer genes are
mapped always in the same positions, according to the representation achieved in the fourth level of (A), in which all genes are aggregated and the
Fruchterman–Reingold is performed to achieve the optimal distribution of vertices.
RESULTS
The first analysis we performed on the achieved multi-layer
graphs was to compute the distribution of the strength and degree
of the graph nodes—which identify genes or proteins, depending
on the considered layer—in order to identify the most important
genomic players before and after the E2 stimulation. To this
end, Figure 5 proposes four charts displaying the top 20 genes in
function of node strength and degree. Stacked bars represent each
single layer separately (GO functional annotations, chromosome
conformation and protein-protein interactions), the aggregate
layer (the layer with all the nodes represented in the other layers)
and the whole multi-layer model.
In particular, looking at Figure 5A shows the top 20 genes
considering the strength of the nodes in the graph before the
stimulation, which should be compared to Figure 5B, showing
the top 20 genes considering the strength of the nodes in the
graph after the stimulation. At the same way, Figure 5C shows
the top 20 genes considering the degree of the nodes in the graph
before the stimulation, which should be compared to Figure 5D,
showing the top 20 genes considering the degree of the nodes in
the graphs after the stimulation.
CADPS is the gene showing the highest strength and
degree before E2 the stimulation, with a considerable margin
on the other nodes. This gene encodes an endocrine-specific
cytosolic and peripheral membrane protein required for the
Ca2+-regulated exocytosis of secretory vesicles. CADPS is
down-regulated in many types of tumors, although it has not
been reported as associated to breast cancer (Mosca et al., 2010).
In the pre-stimulus multi-layer model, we can see a similar
distribution of genes in the top list of node strength and degree,
since 18 out of 20 genes are shared between the two lists.
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FIGURE 4 | Multi-layer graph for the breast cancer cell line MCF-7 at time point 4 h after E2 stimulation, considering ESR1 as seed gene. (A) represents
the stacked multilayer (interlayer edges have been removed for readability), while (B) shows each single layer separately. In both panels, from left to right, the first layer
represents the functional similarity of genes relying on the BP domain of GO, as computed by InteGO2. On this network, breast cancer mutation data are mapped,
according to the COSMIC database (colors and dimensions of nodes indicate the number of samples with mutations in the COSMIC dataset for each gene). The
second layer represents the conformation of the chromatin in the nucleus, according to Hi-C experiments analyzed using NuChart. Vertices are colored according to
the methylayion of genes, relying on MeDIP-seq experiments. The third layer represents a protein-protein interaction network according to the data reported in the
STRING database. Gene expression data have been mapped on this graph and vertices are represented accordingly. Please note that in each layer genes are
mapped always in the same positions, according to the representation achieved in the fourth level of (A), in which all genes are aggregated and the
Fruchterman–Reingold is performed to achieve the optimal distribution of vertices.
According to COSMIC (Forbes et al., 2015), other interesting
cancer related genes are present in these top lists, such as
EPHA5, which belongs to the ephrin receptor subfamily of
the protein-tyrosine kinase family and PIP4K2B, an enzyme
that catalyzes phosphorylation, showing kinase activities. More
precisely, EPHA5 is implicated in mediating developmental
events and plays a critical role in the regulation of carcinogenesis,
since it has been demonstrated to be a promoter of methylation
in breast cancer (Li et al., 2015). PIP4K2B has been linked to the
regulation of gene transcription, to TP53 and AKT activation,
and to the regulation of cellular reactive oxygen accumulation.
Low PIP4K2B expression associates with increased tumor
size and distant metastasis, whereas high PIP4K2B expression
strongly associates with ERBB2 expression (Keune et al.,
2013).
Considering pathways, we can see genes related to DNA
replication, such as POLA1 RPA1, RPA2, RAP3, SMC6 (p <
4.1e−8), which all share a high number of edges in the protein-
protein interaction layer and belong to the neighborhood
of ESR1, although they do not present many mutations.
Moreover, we can see proteins from the protein phosphorylation
pathway, GUCY2C, GUCY2F, PRKG1, RET, TEX14 (p< 1.5e−3),
which are involved in AKT regulation and signaling during
tumorigenesis (Lin et al., 2010).
After the E2 stimulation, at the top of both the node degree
and strength lists we find IMMP2L. This gene encodes an
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FIGURE 5 | Stacked histogram plots of centrality measures. This figure shows the top 20 genes considering the strength and degree of the nodes in the graphs
before and after E2 stimulation. Each grouped histogram represents each single layer separately, the aggregate layer (the layer with all the nodes represented in the
other layers) and the whole multi-layer model. In particular, (A) shows the top 20 genes considering the strength of the nodes in the graphs before the stimulation; (B)
shows the top 20 genes considering the strength of the nodes in the graphs after the stimulation; (C) shows the top 20 genes considering the degree of the nodes in
the graphs before the stimulation; (D) shows the top 20 genes considering the degree of the nodes in the graphs after the stimulation.
inner mitochondrial membrane protease-like protein, which
is required for processing cytochromes inside mitochondria.
Numerous studies reported that IMMP2L may act as risk factor
for neurological disease (Gimelli et al., 2014) and it has been
associated with breast cancer (Mosca et al., 2010), although its
role is not clear. Interestingly, we can see that ESR1 appears in
both the lists, which provides an indication of its increasing role
in responding to the estrogen stimulation.
Considering cancer related genes, we find very important
oncogenes such as AKT, a serine/threonine-specific protein
kinase that plays a key role in multiple cellular processes such as
glucose metabolism, apoptosis, cell proliferation, transcription,
and cell migration (Paplomata and O’Regan, 2014), and
PTK2, a focal adhesion-associated protein kinase involved in
cellular adhesion and spreading processes (Sulzmaier et al.,
2014). It has been shown that when PTK2 is blocked, breast
cancer cells became less metastatic due to decreased mobility
(Sulzmaier et al., 2014). Another interesting gene is PTPRK,
a member of the protein tyrosine phosphatase (PTP) family,
known to be a signaling molecule that regulate a variety
of cellular processes including cell growth, differentiation,
mitotic cycle, and oncogenic transformation (Sun et al., 2013).
Moreover, FYN is a Proto-oncogene tyrosine-protein kinase
of the Src family of kinases, typically associated with T-cell
and neuronal signaling in development and normal cell
physiology. Disruptions FYN signaling pathways often have
implications in the formation of a variety of cancers (Saito et al.,
2010).
From the pathways point of view, after E2 stimulation, we
can see that enriched processes are signal transduction, in which
AKT1 CSF1R ESR1 MAP2K6 PTPRK RPS6KB1 are involved (p
< 8.1e−3), and platelet activation, in regards of the genes AKT1,
FYN, DGKB, and DGKI (p< 2.9e−4).
More generally, the analysis of the histograms shows that after
the stimulation there are more breast cancer related genes, able
to accumulate more mutations, as it emerges from comparing
left and right panels (please note that they have different scales).
After the stimulation there are more connections in the layer
representing cancer mutations, according to the GO functional
annotation network. This is interesting because it shows how
mutated genes can be activated by the E2 stimulation, including
cell cycle related genes, such as SYNE1, NEK7, and RPS6KB1 (Li
et al., 2015).
A similar situation is described by the centrality plots reported
in Figure 6, which represent the hub centrality against node
degree and strength, before and after E2 stimulation. All the
scatter plots represent each single layer separately, the aggregate
layer (the layer with all the nodes represented in the other layers)
and the whole multi-layer model. In particular, Figure 6A shows
the scatter plot of hub centrality against node degree before the
stimulation, which should be compared with Figure 6B, showing
the scatter plot of hub centrality against node degree after the
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FIGURE 6 | Scatter plots of hub centrality. This figure shows the trend of the hub centrality against node degree and strength, before and after E2 stimulation. All
scatter plots represent each single layer separately, the aggregate layer (the layer with all the nodes represented in the other layers) and the whole multi-layer model. In
particular: (A) shows the scatter plot of hub centrality against node degree before the stimulation; (B) shows the scatter plot of hub centrality against node degree
after the stimulation; (C) shows the scatter plot of hub centrality against node strength before the stimulation; (D) shows the scatter plot of hub centrality against node
strength after the stimulation.
stimulation. On the other hand, Figure 6C shows the scatter plot
of hub centrality against node strength before the stimulation and
should be compared with Figure 6D, showing the scatter plot of
hub centrality against node strength after the stimulation.
Similarly to what happens in Figure 5, also in this case we can
clearly see that the multi-layer graph become more complex after
the E2 stimulation, in particular due to the layer representing
cancer mutations. Following the orange dots in the scatter plots,
we can see that many cancer related genes turn into the network,
carrying a lot of different mutations. Moreover, we can see that
the chromosome conformation layer becomes more connected,
in function both of the degree and strength of the node, as
discussed above. On the other hand, this do not correspond
to an increase of the protein-protein interactions at the gene
expression level, which shows a different trend compared to the
other two layers. For a full description of the centrality measures
computed with MuxViz on the 0 and 4 h multi-layer models see
Supplementary Tables 1, 2, respectively.
The same association between the functional gene level and
the chromosome conformation level, as well as the differences
of these two layers with the protein-protein interaction level,
can be also seen in Figure 7. These plots show the correlation
between each pair of layers, before and after the stimulation,
calculated using the Spearman correlation, which uses ranks to
compare non-linear relationship, between the node strength of
each level and their counterparts in the other layers. In particular,
Figure 7A shows the inter-layer Spearman correlation before
the stimulation, while Figure 7B shows the inter-layer Spearman
correlation after stimulation.
This multi-layer correlation is very important, since it
highlights the progression of the E2 signal from one layer to
the other. In particular, we can see that after the stimulation the
folding of the genome changes, due to a general condensation of
the chromatin, which brings many genes in the neighborhood of
the seed gene ESR1, although the impact on gene expression is
still limited, as reported also in previous works (Cicatiello et al.,
2010; Rao et al., 2014). On the other hand, the anti-correlated
profile of methylation and gene expression appears quite clearly,
also presenting an increasing trend after E2 stimulation. It
is predictable that many hours after the E2 stimulation the
impact of these genome rearrangements will be more effective in
modifying the gene expression and the metabolic profile of cells.
The power of this multi-layer approach is in the capability
of providing a global view of cancer evolution from a multi-
omic point of view. For this reason, we further investigated the
achieved results, in order to verify the type of mutations in
the genes of the two graphs, before and after the stimulation.
In particular, we are interested in verifying if accumulated
mutations are drivers or passengers and their correlation with the
genome conformation.
Moreover, we annotated all the SNPs through a score
describing their pathogenic potential. Although there are many
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FIGURE 7 | Multi-layer correlation. This figure shows the correlation between each pair of layers, before and after the stimulation, calculated using the Spearman
correlation coefficient between the strength of nodes and their counterparts in the other layers. In particular: (A) shows the inter-layer Pearson correlation (Spearman
correlation is reported in brackets) before the stimulation: (B) shows the inter-layer Pearson correlation (Spearman correlation is reported in brackets) after the
stimulation.
computational prediction algorithms capable of analysing the
functional consequences of SNPs, we employed the Functional
Analysis through HiddenMarkovModels (FATHMM) algorithm
(Shihab et al., 2014), a sequence-based method that combines
evolutionary conservation in homologous sequences with
pathogenicity weights, representing the overall tolerance of
proteins to mutations. We adopted this solution because the
FATHMM algorithm has a cancer specific weighting schema,
which substantially improves its predictive performances in
relation to other tools.
Table 1 provides a statistical description of the mutations
included in the model, before and after the stimulation. In
particular, according to the FATHMM algorithm, mutations
with a score above the 0.7 threshold are classified as drivers,
while mutations below this threshold are considered passengers.
As shown in Table 1, before the stimulation our multi-
layer model consists of 114 genes, potentially carrying 15,611
mutations, 10,952 of which having pathogenic potential. After
the stimulation, the number of genes increases to 353 (due to the
changes in the chromosome conformation), and the total number
of potential mutations reaches 63,689, of which 44,678 with a
pathogenic impact.
Considering that metabolic activities are altered in cancer
cells and that these alterations support the acquisition and
maintenance of malignant properties (DeBerardinis and
Chandel, 2016), we also analyzed how many SNPs belong to
metabolic genes. Using HumanMine (Smith et al., 2012), we
identified genes and mutations involved in metabolic pathways:
as reported in Table 1, after the stimulation we can see that the
number of SNPs playing a role in metabolic processes increases,
both considering driver and passenger mutations. Moreover,
looking at the mean and median values of the scores distribution,
we can see that there is an average increase of the pathogenic
potential after the stimulation, taking into account both driver
and passenger mutations.
In order to test the significance of the changes occurred after
the E2 stimulation, we tested the enrichment of SNPs associated
to breast cancer using a hypergeometric test. In particular, we
considered all the human genes as reference and the genes
belonging to the graph as sample, using the COSMIC database to
identify SNPs related to breast cancer. As expected, considering
that the seed gene ESR1 is related to breast cancer, both at 0 and
4 h the graphs are enriched in SNPs associated to breast cancer,
with p < 9.3e−20 and p < 1.74e−27 respectively. It is worthy to
note that after the E2 stimulation the enrichment is more evident
than at the beginning of the experiment, which highlights a
correlation between spatially related genes and functional related
genes.
DISCUSSION
Multi-omic approaches can provide very much desirable
progresses in non-invasive diagnostic methods, to enable early
diagnosis, in pre- and post-operative staging, and to assist
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TABLE 1 | Statistical description of SNPs pathogenicity before and after E2 stimulation.
Time (hours) Type Number of SNPs Number of SNPs in Metabolic Pathways FATHMM Mean FATHMM Median FATHMM Variance
0 Passenger 4659 422 0.190490 0.16433 0.019447
0 Driver 10952 869 0.956110 0.97762 0.003345
0 All 15611 1662 0.834172 0.96973 0.07913
4 Passenger 19011 1848 0.210717 0.21949 0.018901
4 Driver 44678 5707 0.965158 0.98166 0.002377
4 All 63689 9693 0.881392 0.974510 0.057060
SNPs are annotated as DRIVER or PASSENGER according to their FATHMM score (threshold = 0.7). The third column shows the number of SNPs for each class, while the fourth
column reports the number of metabolic SNPs for each class. In the following columns descriptive statistics about the FATHMM scores of the identified SNPs are reported.
in selecting the most suitable therapeutic methods and post-
treatment decisions. In this sense, chromosome conformation
can help in identifying novel biomarkers (Michailidou et al.,
2013), which are absent in healthy persons and present in cancer,
especially at early developmental stage of the disease, in order to
use them in screening tests (Merelli et al., 2013a).
To improve our understanding of the disease progression
and to assist biologists in the interpretation of the results,
mathematical models can be designed to encompass the
modifications of the 3D genome conformation in cancer cells,
in order to predict the survival probabilities of patients with
different genetic expression and epigenetic patterns. In particular,
using multi-omic data, it will be possible to select the best
medical treatment for each patient and follow the results of
drugs administration with more awareness. Moreover, survival
probabilities generated with these models will be useful to
identify the presence of hiddenmarkers currently not considered,
proving a full implementation of the translational medicine
paradigm.
Although many different approaches can be used for multi-
omic data integration, some basic assumption should be made
a priori. First, we must decide whether or not to use graphs for
modeling the interactions among variables (Risca and Greenleaf,
2015). Our choice was to use a graph-based approach in order
to exploit the power of the topological description provided
by Hi-C data, completing this information with other scalar
characterization of vertices. Although this approach is not
applicable in all cases, mainly because Hi-C data are not yet
widely available, we think that this representation can be very
useful, in particular when it is possible to include it in a multi-
level model like the one presented.
The second criterion is whether the approach should be
Bayesian (Korbel and Lee, 2013) or not, which depends on the
possibility of creating a priori reasonable assumptions about
the data probability distribution, parametric or non-parametric,
and to compute the posterior probability distribution making
use of the Bayes’ rule as data becomes available. Although this
is a very interesting option, our knowledge of the multi-level
interactions, which can occur in co-expression, co-regulation and
co-localization, are still very difficult to model.
Although modeling a priori can be prohibitive, we can suggest
the application of some modeling techniques to interpret, a
posteriori, multi-layer representations like the one we presented
in this work. The idea is to go beyond the descriptive analysis
(such as node degree, node strength, walks, paths, distances,
centrality measures, cluster coefficients, inter-layer diagnostics,
communicability; Estrada and Gómez-Gardeñes, 2014), by
creating randomized network ensembles that can help in the
comprehension of the network model.
More precisely, approaches used for knowledge
representation can be employed to stochastically model
multi-omic data, such as the Exponential-family Random
Graph Models (ERGM) (Hunter et al., 2008), scale-free network
models (Barabási–Albert model) (Albert and Barabási, 2002) and
Multi-layer graph entropy (Bianconi, 2007). In particular, ERGM
are extremely useful for network analysis, since they allow the
creation of probability distributions by which some peculiarities
of the graph can be extrapolated. The use of this approach will
allow the probabilities to be tested, for example, to verify if
edges are functions of specific genomic features or to measure
the significance of having edges in relation to the specific
properties of nodes. Considering that the organization of the
chromatin inside the nucleus can be itself a disease biomarker,
since specific reorganizations of the genome can be used for the
early identification of some diseases, scale-free approaches to
network modeling will be extremely useful to capture the “fold of
folds” pattern of the genome. Moreover, clustering approaches,
ontology annotations, and deep learning techniques can be
applied to multi-layer graphs, in order to capture the impact of
gene co-localization on biochemical pathways’ regulation, in a
systems biology perspective.
The combination of integration models, such as the one
presented here, with variance analysis on expression and
epigenetic experiments, achieved through the integration of
publicly available databases, as well as on the topology of the
networks, can be the winning strategy for translational medicine
(see Figure 8). It is very important to establish which variations
are normal inside a specific experiment and which variations
are able to distinguish between normal and pathological
samples (the bench part of the translational medicine schema).
Moreover, variations in the omic profiles can characterize the
progression of the disease during time, describing its temporal
evolution according to the provided therapies. These confidence
intervals will be then compared with the patient data, in
order to better characterize the pathology (the bed part of the
translational medicine schema). In this context, resources like
METABRIC (Curtis et al., 2012) (Molecular Taxonomy of Breast
Cancer International Consortium) will be very important to
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FIGURE 8 | Multi-layer based representation of multi-omic data to implement the translational medicine model. In the upper-left panel the “bench” part of
the model is represented, in which statistics are used to define confidence intervals for multi-omic data, in order to classify physiological and pathological behaviors.
This information is the core of the multi-layer graph representation, since it allows to define confidence intervals for vertices and edges, which describe normal
variations inside the experiments and variations that are symptomatic of the different disease stages. In the lower-left part of the Figure, the “bed” part of the model is
represented, in which the omic information of the patient are reported in the electronic health record. This data will be integrated in the multi-layer model, in order to
profile and interpret the specific patient, taking into account all the available multi-omics. In the right part of the figure the “community” part of the translational
medicine model is represented, where inferred information is used to improve the current decision trees for treatment identification and to perform better predictions
about patient survival possibilities.
identify cancer mutations able to drive genome conformational
changes.
Providing a better characterization of the disease, we will
achieve better treatment definitions. Expanding this idea, it will
be possible to use confidence intervals for the diagnosis of
disease co-morbidity by identifying specific patterns in multi-
omic variability. At the same time, this multi-omic approach will
be useful to improve the prediction of the survival possibility
of patients, as the integration of more information about the
disease can make estimators such as the Kaplan-Meier curve
more precise.
CONCLUSIONS
It is now clear that cancer is a multi-step process, resulting from
the accumulation of both genetic and epigenetic alterations of
the genome. Gene mutations and epigenetic modifications have
been initially viewed as two separate mechanisms participating in
carcinogenesis. This is the reason why the study of tumors should
be performed using different profiling strategies, including
mutation analyses, phylogenetic trees, copy number variations,
DNA methylations, histone modifications, transcriptomic
experiments and chromatin conformation capture technologies,
which may collectively be defined as omics. Through multi-omic
analysis, researchers want to identify genes and pathways
deregulated in cancer and to reveal biomarkers that may be
useful for the detection and the management of the disease.
Such analysis will enhance our understanding of the biology of
cancer, leading to the discovery of novel diagnostic, prognostic,
and therapeutic approaches that will ultimately improve the
disease outcomes. An integrative model of these omic data will
improve the predictive power of survival curves, allowing the
definition of novel biomarker, and will provide novel multi-omic
based guidelines for cancer, favoring the identification of the best
treatment for each patient.
In this work we presented an approach for multi-omic
data modeling using multi-layer networks, which allows the
integration of graph-based representations and scalar genomic
data. We tested this framework for the analysis of multi-omic
data from theMCF-7 cell line, a well-known breast cancer model.
At first, our chromatin conformation data analysis revealed that
gene-rich genomic regions tend to interact more with each other
after E2 stimulation. Second, we were able to show correlations
between changes in the inter-chromosomal conformation and
other omic actors, such as mutation profiles and variations of
the epigenetics patterns. Moreover, using our model, we were
able to characterize the accumulation of driver and passenger
mutations in breast cancer, allowing a better description of
the damage spreading during the evolution of the disease.
This mutation enrichment can be also characterized focusing
on specific pathway, as represented by the GO-based network,
looking for example at metabolic processes that are so important
for cancer development.
This is in line with the idea that the organization of the
DNA in the nucleus represents an integrating factor for many
omic signals. Although challenges about the comprehension
of 3C data must still be addressed, such as the management
of genetic variants in order to distinguish the conformations
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of the two homologous chromosomes, the possibility of
studying long-range DNA interactions opens new perspectives
for cancer research. Researches about genome 3D organization,
and related epigenetic patterns in the nucleus, will be very
important to understand cancer progression, providing novel
biomarkers to identify the early onset of the disease. This
can be achieved by integrating variance analyses of multi-omic
data in this model, relying on statistics about physiological
and pathological molecular patterns, improving both treatment
decision trees and survival estimators, such as the Kaplan-Meier
curves.
In our vision, different cancer omics—mutations, chromatin
conformation, epigenetics, gene expression, variations in the
metabolic pathways—will be calibrated performing a quality
assessment of the data on the basis of the mutual consistence,
in order to achieve a model for interpreting patient data. In
other words, omic data from patients should be considered
in terms of variances, which will be used to take decisions
by comparing results with well-established network models of
cancer, describing the temporal evolution of the disease along
with the appropriate therapies. The open problem is to create
suitable genomic and bioinformatic tools for these clinical
applications.
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